-
1
Neurodegenerative diseases, particularly Alzheimer's, affect millions globally, with numbers expected to rise significantly by 2050.
-
2
Brain MRI is crucial for diagnosing cognitive impairment, assessing structural changes, and excluding mimicking diseases.
-
3
FDG-PET/CT is used for differential diagnosis in neurodegenerative disorders, enhancing diagnostic accuracy through statistical mapping.
-
4
Key MRI assessment items include microvascular ischemic disease, sulcal/ventricular dilatation, regional atrophy, and microhemorrhage.
-
5
White matter hyperintensities are linked to cognitive decline and vascular risk factors, highlighting their importance in neuroimaging.
